14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

$39.85 (0.23%)

Volume: 718.133k

Closed: May 23, 2022

Hollow Logo Score: 1.145

Cytokinetics Stock Forecast

BUY SELL NASDAQ:CYTK
$39.85 (0.23%)

Volume: 718.133k

Closed: May 23, 2022

Score Hollow Logo 1.145

Cytokinetics Stock Forecast NASDAQ:CYTK

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-16 100.75% Mizuho $54.00 $80.00 Maintains Buy
2022-05-05 50.56% Needham $52.00 $60.00 Maintains Buy
2022-04-29 88.21% HC Wainwright & Co. $69.00 $75.00 Maintains Buy
2021-12-22 38.02% Oppenheimer $55.00 Initiates Coverage On Outperform
2021-12-21 73.15% HC Wainwright & Co. $62.00 $69.00 Maintains Buy
2021-12-10 45.55% JP Morgan $58.00 Initiates Coverage On Overweight
2021-12-01 35.51% Mizuho $45.00 $54.00 Maintains Buy
2021-11-04 55.58% HC Wainwright & Co. $58.00 $62.00 Maintains Buy
2021-10-08 12.92% Morgan Stanley $38.00 $45.00 Maintains Overweight
2021-10-07 88.21% Jefferies $75.00 Initiates Coverage On Buy
2021-08-06 45.55% HC Wainwright & Co. $53.00 $58.00 Maintains Buy
2021-07-20 0.38% Barclays $28.00 $40.00 Maintains Overweight
2021-07-19 20.45% Needham $33.00 $48.00 Maintains Buy
2021-07-19 33% HC Wainwright & Co. $41.00 $53.00 Maintains Buy
2021-04-19 -12.17% Morgan Stanley $24.00 $35.00 Maintains Overweight
2021-03-12 25.47% Wolfe Research $50.00 Initiates Coverage On Outperform
2021-01-20 2.89% HC Wainwright & Co. $22.00 $41.00 Maintains Buy
2020-12-16 -39.77% Morgan Stanley $22.00 $24.00 Maintains Overweight
2020-11-16 -44.79% Morgan Stanley $24.00 $22.00 Maintains Overweight
2020-10-29 -59.85% Goldman Sachs $16.00 Initiates Coverage On Neutral
2020-10-12 -39.77% Morgan Stanley $35.00 $24.00 Maintains Overweight
2020-10-08 7.9% HC Wainwright & Co. $59.00 $43.00 Maintains Buy
2020-07-23 48.06% HC Wainwright & Co. $38.00 $59.00 Maintains Buy
2020-07-23 -9.66% Piper Sandler $33.00 $36.00 Maintains Overweight
2020-07-16 12.92% Needham $34.00 $45.00 Maintains Buy
2020-07-14 -4.64% HC Wainwright & Co. $35.00 $38.00 Maintains Buy
2020-07-10 -2.13% Raymond James $39.00 Initiates Coverage On Strong Buy
2020-07-07 -12.17% Morgan Stanley $29.00 $35.00 Maintains Overweight
2020-05-12 -27.23% Morgan Stanley $25.00 $29.00 Maintains Overweight
2020-05-05 -22.21% Mizuho $31.00 Initiates Coverage On Buy
2020-04-17 -42.28% Cantor Fitzgerald $12.00 $23.00 Reiterates Overweight
2020-04-09 -37.26% Morgan Stanley $14.00 $25.00 Upgrades Equal-Weight Overweight
2019-09-06 -49.81% Cantor Fitzgerald $14.00 $20.00 Reiterates Overweight

CYTK Stock Trend

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 9.62% during the next 3 months and, with a 90% probability hold a price between $38.55 and $49.56 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $35.23 $40.25 $45.27
2022-05-26 $35.30 $40.32 $45.34
2022-05-27 $35.36 $40.38 $45.40
2022-05-31 $35.43 $40.45 $45.47
2022-06-01 $35.49 $40.51 $45.53
2022-06-02 $35.56 $40.58 $45.60
2022-06-03 $35.62 $40.64 $45.66
2022-06-06 $35.69 $40.71 $45.73
2022-06-07 $35.75 $40.77 $45.79
2022-06-08 $35.82 $40.84 $45.86
2022-06-09 $35.88 $40.90 $45.92
2022-06-10 $35.95 $40.97 $45.99
2022-06-13 $36.01 $41.03 $46.05
2022-06-14 $36.08 $41.10 $46.12
2022-06-15 $36.14 $41.16 $46.18
2022-06-16 $36.21 $41.23 $46.25
2022-06-17 $36.27 $41.29 $46.31
2022-06-21 $36.34 $41.36 $46.38
2022-06-22 $36.40 $41.42 $46.44
2022-06-23 $36.47 $41.49 $46.51
2022-06-24 $36.53 $41.55 $46.57
2022-06-27 $36.60 $41.62 $46.64
2022-06-28 $36.66 $41.68 $46.70
2022-06-29 $36.73 $41.75 $46.77
2022-06-30 $36.79 $41.81 $46.83
2022-07-01 $36.86 $41.88 $46.90
2022-07-05 $36.92 $41.94 $46.96
2022-07-06 $36.99 $42.01 $47.03
2022-07-07 $37.05 $42.07 $47.09
2022-07-08 $37.12 $42.14 $47.16

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. It is developing tirasemtiv, a fast skeletal muscle troponin activator that is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis; CK-2127107, which is in Phase II clinical trials for... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT